These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 22433918

  • 1. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R, Sockalingam S, Shahrizaila N, Cheah TE, Zain AA, Goh KJ.
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [Abstract] [Full Text] [Related]

  • 2. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER, Fang AJ, Wallace DJ, Weisman MH.
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [Abstract] [Full Text] [Related]

  • 3. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity.
    Calixto OJ, Poveda S, Meneses-Toro MA, Vera-Parra EC, Romero-Sánchez C, Guzman Molano LF, Bello-Gualtero JM.
    Lupus; 2023 Aug; 32(9):1123-1125. PubMed ID: 37369195
    [Abstract] [Full Text] [Related]

  • 4. [Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjögren syndrome: a case report].
    Hatano T, Fukuda M, Shiotsuki H, Miwa H, Urabe T, Mizuno Y.
    Rinsho Shinkeigaku; 2006 Mar; 46(3):203-9. PubMed ID: 16642931
    [Abstract] [Full Text] [Related]

  • 5. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
    Julio PR, Cortês MMM, Costallat LTL, Gaino JZ, França MC, Appenzeller S.
    Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
    [Abstract] [Full Text] [Related]

  • 6. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM, Sherman WH, Brannagan TH.
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [Abstract] [Full Text] [Related]

  • 7. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): An Uncommon Manifestation of Systemic Lupus Erythematosus (SLE).
    Abraham H, Kuzhively J, Rizvi SW.
    Am J Case Rep; 2017 Sep 12; 18():980-983. PubMed ID: 28894082
    [Abstract] [Full Text] [Related]

  • 8. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F, Costedoat-Chalumeau N, Bouhour F, Rousset H, Vial C.
    Rev Neurol (Paris); 2007 Sep 12; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [Abstract] [Full Text] [Related]

  • 9. [Association of systemic lupus erythematosis and myasthenia gravis. A new case report].
    Louzir B, Ben Abdelhafidh N, Bahri M, M'Sadek F, Ksontini I, Boussema E, Othmani S.
    Tunis Med; 2003 Dec 12; 81(12):963-6. PubMed ID: 14986533
    [Abstract] [Full Text] [Related]

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus.
    Zoilo MA, Eduardo B, Enrique F, del Rocio MV.
    Rheumatol Int; 2010 May 12; 30(7):965-8. PubMed ID: 19536546
    [Abstract] [Full Text] [Related]

  • 11. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J.
    Acta Neurol Scand; 2005 Aug 12; 112(2):115-25. PubMed ID: 16008538
    [Abstract] [Full Text] [Related]

  • 12. Clinical features of Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE.
    Wang J, Zhang Z, Qian J, Zhang S, Qiao L, Li M, Zhao Y, Zeng X.
    Lupus Sci Med; 2024 Oct 10; 11(2):. PubMed ID: 39389620
    [Abstract] [Full Text] [Related]

  • 13. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC.
    J Peripher Nerv Syst; 2012 May 10; 17 Suppl 2():34-9. PubMed ID: 22548621
    [Abstract] [Full Text] [Related]

  • 14. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
    Sanz PG, García Méndez CV, Cueto AL, Silva VB, Walther JC, Diez RA, Martins S, Giannaula RJ.
    Rheumatol Int; 2012 Dec 10; 32(12):4061-3. PubMed ID: 21922339
    [Abstract] [Full Text] [Related]

  • 15. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
    RMC Trial Group.
    Lancet Neurol; 2009 Feb 10; 8(2):158-64. PubMed ID: 19136303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA.
    Rev Neurol (Paris); 2002 Dec 10; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G, Pestronk A, Al-Lozi M.
    Arch Neurol; 2005 Feb 10; 62(2):249-54. PubMed ID: 15710853
    [Abstract] [Full Text] [Related]

  • 20. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML, Vinik AI.
    J Diabetes Complications; 2015 Mar 10; 29(2):313-7. PubMed ID: 25466645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.